Claes Gustafsson, cofounder of ATUM, discusses how his business made an epic pivot that got the company fighting COVID-19 by supplying cellular components to help build antibody tests, drugs and vaccines, and why never taking VC funding helped him do it.
More videos at matthiggins.com
27 авг 2024
